Intekrin Therapeutics Inc — Form D

Intekrin Therapeutics Inc of LOS ALTOS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-04-02. The offering totals $21.9M, of which $21.4M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2009-04-02
Form: D
Accession: 0001360245-09-000003
Industry: Pharmaceuticals
Exemptions: 06
Total offering: $21.9M
Amount sold: $21.4M
Remaining: $507K
Investors: 12
Date of first sale: 2008-07-01
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-88610

Issuer

Name: Intekrin Therapeutics Inc
CIK: 0001360245
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2005
Address: 4300 EL CAMINO REAL, LOS ALTOS, CA, 94022
Phone: 6509415501

Officers, directors & promoters (19)

Name	Role	Location
Alex M DePaoli, M.D.	Executive Officer	Los Altos, CA
Linda Slanec Higgins	Executive Officer	Los Altos, CA
Dennis M Lanfear	Executive Officer	Redwood City, CA
Michael A Nazak	Executive Officer	Los Altos, CA
Carmen R Rodriguez, M.S.c	Executive Officer	Los Altos, CA
Dennis M Lanfear	Director	Redwood City, CA
James I Healy, M.D., Ph.D.	Director	Redwood City, CA
Lowell E Sears	Director	Bozeman, MT
Harold E Selick, Ph.D.	Director	Milpitas, CA
Martin I Freed, M.D., FACP	Director	Los Altos, CA
David G Lowe, Ph.D.	Director	Palo Alto, CA
Carmen R Rodriguez, M.Sc.	Executive Officer	Los Altos, CA
Kathleen M Lee, Ph.D.	Executive Officer	Los Altos, CA
David M Brand	Director	Los Altos, CA
Geoffrey M Parker	Executive Officer	Los Altos, CA
Linda Slanec Higgins, Ph.D.	Director	Los Altos, CA
Linda Slanec Higgins, Ph.D.	Executive Officer	Los Altos, CA
Samuel P Wertheimer, Ph.D.	Director	New York, NY
Roman J Skowronski, M.D., Ph.D.	Executive Officer	Los Altos, CA

Other filings by this issuer (1)

Filed	Form	Offering	Sold
2010-06-14	D	$5.0M	$2.3M

More